Neuropathologically, DLB is characterized by neuronal inclusions containing aggregates of phosphorylated α-synuclein with varying distribution patterns, as well as frequent co-pathology with Alzheimer’s disease (AD) markers (β-amyloid and phosphorylated tau accumulation). The gene discussed is MAPT; the disease is Alzheimer disease.